Fred Hutch Cancer Center physicians and scientists are seeking better ways to treat acute lymphoblastic leukemia (ALL). They are testing new treatments and finding new ways to use current treatments.
Through this work, we are looking for answers to two main questions: How can we do even better at controlling or curing ALL? How can we make treatments less toxic and easier on patients?
In recent years, research on targeted therapies and immunotherapies has found new ways to put ALL into remission and make treatment less toxic for patients. Fred Hutch is a national leader in advancing these and other treatment options.
Acute Lymphoblastic Leukemia Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
How Clinical Trials Work
When your care team designs your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same physicians and nurses as you would for standard therapy.
Your care team will talk with you if you might want to join a particular study and why, so you can make the decision that’s best for you.
We have clinical trials for all classifications of ALL, from newly diagnosed to refractory. The trials are testing dozens of medicines, including:
- Chemotherapy regimens
- Targeted therapies
- Immunotherapies, including cellular immunotherapies
Our ALL Researchers and Faculty
Our scientists and providers work together to prevent, diagnose and treat ALL as well as other cancers and diseases. The lab research and clinical research they do are essential parts of the scientific process that leads to new treatments and better care. Many of our ALL providers also do research in addition to seeing patients. Clinical trials can also be a way for patients to get early access to new leading-edge therapies. Our research teams are running many clinical studies for people with ALL.
See below for our researchers and faculty or view our ALL care team providers.
